Dec 2, 2025, 09:51
Time to Refocus on NSTEMI․ Why This State-of-the-Art Review Matters
Davide Capodanno, Professor of Cardiology at University of Catania, editor-in-Chief of EuroIntervention, shared on X:
”We always talk about STEMI—and rightly so—but shouldn’t we also focus on NSTEMI? It is no less challenging; in fact, in several respects it is even more complex, as patients are typically older, more often multivessel, and clinically more difficult to manage. This is why this state-of-the-art review on the diagnosis, risk stratification, and early management of non–ST-segment elevation acute coronary syndromes, in my view, deserves careful reading. ”
Find more information here.
Find more posts on Hemostasis Today.
-
Jan 16, 2026, 13:15Paul Bolaji Invites You to Join World Stroke Organization Membership
-
Jan 16, 2026, 12:59Prithu Sundd on The Role of CD39 Polymorphism in Enabling Pulmonary Thrombosis in SCD
-
Jan 16, 2026, 12:46Gregory Piazza on The Effect of Enduring Risk Factors in Provoked VTE
-
Jan 16, 2026, 12:33Fernando Corrales-Medina on Heavy Periods in Teens: Don’t Miss a Bleeding Disorder
-
Jan 16, 2026, 06:05Wolfgang Miesbach on Jacob Lund’s Study: How to Define FVIII Bioequivalence
-
Jan 16, 2026, 05:52Piotr Czempik Shares His Latest Contribution to Acta Haematologica Polonic
-
Jan 16, 2026, 05:44Florian Piekarski on Perioperative Blood Management When Allogeneic Transfusion is Not Aaccepted
-
Jan 16, 2026, 05:00Plaque Rupture and Thrombosis
-
Jan 16, 2026, 04:52Arterial Disease Across Vascular Beds․ Lipoprotein(a) as a Causal Risk Factor